Last reviewed · How we verify
Pigment Solution Program
At a glance
| Generic name | Pigment Solution Program |
|---|---|
| Sponsor | Dr.dr.Irma Bernadette, SpKK (K) |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effectiveness and Safety of Pigment Solution Program (PSP) as Adjuvant Therapy in Melasma (NA)
- Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pigment Solution Program CI brief — competitive landscape report
- Pigment Solution Program updates RSS · CI watch RSS
- Dr.dr.Irma Bernadette, SpKK (K) portfolio CI